You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
McKinsey
Baxter
AstraZeneca

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for motexafin gadolinium

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug motexafin gadolinium?

motexafin gadolinium is an investigational drug.

There have been 36 clinical trials for motexafin gadolinium. The most recent clinical trial was a Phase 3 trial.

The most common disease conditions in clinical trials are Lung Neoplasms, Lymphoma, and Nervous System Neoplasms. The leading clinical trial sponsors are Pharmacyclics LLC., National Cancer Institute (NCI), and Northwestern University.

Recent Clinical Trials for motexafin gadolinium
TitleSponsorPhase
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's LymphomaSpectrum Pharmaceuticals, IncPhase 2
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS PolicyNational Cancer Institute (NCI)N/A
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS PolicyAmerican College of Radiology Imaging NetworkN/A

See all motexafin gadolinium clinical trials

Clinical Trial Summary for motexafin gadolinium

Top disease conditions for motexafin gadolinium
Top clinical trial sponsors for motexafin gadolinium

See all motexafin gadolinium clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
McKinsey
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.